Edmond DE Rothschild Holding S.A. acquired a new position in Penumbra, Inc. (NYSE:PEN – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 5,000 shares of the company’s stock, valued at approximately $1,283,000.
Several other hedge funds have also recently bought and sold shares of PEN. GAMMA Investing LLC grew its position in Penumbra by 7.3% in the 2nd quarter. GAMMA Investing LLC now owns 761 shares of the company’s stock worth $195,000 after purchasing an additional 52 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of Penumbra by 70.2% during the second quarter. Parkside Financial Bank & Trust now owns 160 shares of the company’s stock valued at $41,000 after buying an additional 66 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in shares of Penumbra by 0.9% during the second quarter. Louisiana State Employees Retirement System now owns 10,900 shares of the company’s stock worth $2,797,000 after buying an additional 100 shares during the period. New York State Teachers Retirement System grew its holdings in Penumbra by 0.3% in the 2nd quarter. New York State Teachers Retirement System now owns 38,154 shares of the company’s stock worth $9,791,000 after buying an additional 100 shares in the last quarter. Finally, Securian Asset Management Inc. grew its holdings in Penumbra by 3.4% in the 2nd quarter. Securian Asset Management Inc. now owns 3,001 shares of the company’s stock worth $770,000 after buying an additional 100 shares in the last quarter. 88.88% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on PEN. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Penumbra in a research note on Tuesday. Morgan Stanley raised their price target on Penumbra from $260.00 to $266.00 and gave the company an “equal weight” rating in a report on Thursday, July 31st. Evercore ISI restated an “outperform” rating and set a $286.00 price objective on shares of Penumbra in a research note on Thursday, November 6th. Truist Financial reduced their price objective on shares of Penumbra from $310.00 to $300.00 and set a “buy” rating for the company in a report on Wednesday, October 15th. Finally, BTIG Research reissued a “buy” rating and set a $320.00 target price on shares of Penumbra in a research note on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Penumbra presently has a consensus rating of “Moderate Buy” and an average target price of $305.69.
Penumbra Trading Down 0.9%
Shares of Penumbra stock opened at $295.96 on Thursday. The business has a fifty day simple moving average of $258.75 and a 200-day simple moving average of $257.67. Penumbra, Inc. has a fifty-two week low of $221.26 and a fifty-two week high of $310.00. The firm has a market cap of $11.59 billion, a price-to-earnings ratio of 78.71, a price-to-earnings-growth ratio of 2.10 and a beta of 0.51. The company has a quick ratio of 4.04, a current ratio of 6.75 and a debt-to-equity ratio of 0.02.
Penumbra (NYSE:PEN – Get Free Report) last released its earnings results on Wednesday, November 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.07. Penumbra had a return on equity of 11.55% and a net margin of 11.54%.The firm had revenue of $354.69 million for the quarter, compared to analyst estimates of $340.77 million. During the same period in the previous year, the company earned $0.85 earnings per share. Penumbra’s revenue was up 17.8% compared to the same quarter last year. Penumbra has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.
Insider Buying and Selling
In related news, EVP Johanna Roberts sold 1,800 shares of the business’s stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $300.06, for a total value of $540,108.00. Following the sale, the executive vice president directly owned 64,736 shares in the company, valued at $19,424,684.16. The trade was a 2.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Arani Bose sold 7,500 shares of the stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $290.56, for a total transaction of $2,179,200.00. Following the sale, the director directly owned 282,761 shares of the company’s stock, valued at approximately $82,159,036.16. This represents a 2.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 35,330 shares of company stock worth $9,932,319. 4.20% of the stock is owned by insiders.
Penumbra Company Profile
Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Further Reading
- Five stocks we like better than Penumbra
- Stock Market Upgrades: What Are They?
- Why Gold Loves Trump as Much as Trump Loves Gold
- How to Invest in Insurance Companies: A Guide
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- What is the S&P 500 and How It is Distinct from Other Indexes
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.
